4 November 2014
Results of a multi-centre clinical trial in Africa, launched in 2008, to test the efficacy and tolerability of Artesunate-Mefloquine fixed-dose combination in children under 5 years of age with uncomplicated falciparum malaria showed that ASMQ FDC is as safe and efficacious as Artemether-Lumefantrine FDC — Africa’s most widely adopted treatment.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/vBBGGAvVraI/141104091116.htm
